| Application no. and date | 15724070.6 (espacenet) (Federated) (European Patent Register), 20150515 | | Patent/reg. no. and date | DK/EP 3143047, 20220720 | | Publication date | 20170322 | | Priority no. and date | US 201461994427 P, 20140516, US 201462093734 P, 20141218, US 201462095181 P, 20141222 | | EP pub. no. and date |
EP 3143047 20170322 | | Effective date | | | Applicant/owner | Glaxosmithkline Intellectual Property Limited, GSK Medicines Research Centre
Gunnels Wood Road
Stevenage SG1 2NY, GB,
Glaxosmithkline Intellectual Property Management
Limited, GSK Medicines Research Centre
Gunnels Wood Road
Stevenage SG1 2NY, GB | | Applicant ref. no. | V448848DK00 | | Inventor | BLAKE-HASKINS, Angela, One Medimmune Way
Gaithersburg, Maryland 20878, US,
MARSHALL, Tristan, 14200 Shady Grove Road
Rockville, Maryland 20850, US,
O'BERRY, Kristen, One Medimmune Way
Gaithersburg, Maryland 20878, US,
PERKINS, Melissa D., 1776 Centennial Drive
McPherson, Kansas 67460, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , C07K 16/28 (2006.01) | | Title | Belimumab-formulering | | Int. application no. | IB2015053602 | | Int. publication no. | WO2015173782 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
